Cytokinetics Inc (CYTK)

Net profit margin

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Net income (ttm)	US$ in thousands	-526,292	-526,773	-539,661	-430,844	-389,000	-282,145	-215,921	-257,655	-215,314	-228,674	-155,763	-134,989	-127,290	-114,000	-140,398	-131,731	-121,692	-117,520	-109,964	-105,374
Revenue (ttm)	US$ in thousands	7,530	7,815	9,952	95,246	91,781	141,206	139,967	56,649	58,061	9,383	45,819	46,569	47,834	47,611	14,609	16,776	20,245	23,344	29,275	29,730
Net profit margin		-6,989.27%	-6,740.54%	-5,422.64%	-452.35%	-423.83%	-199.81%	-154.27%	-454.83%	-370.84%	-2,437.11%	-339.95%	-289.87%	-266.11%	-239.44%	-961.04%	-785.23%	-601.10%	-503.43%	-375.62%	-354.44%

December 31, 2023 calculation

Net profit margin = Net income (ttm) ÷ Revenue (ttm)
= $-526,292K ÷ $7,530K
= -6,989.27%

Net profit margin is a key financial ratio that indicates the percentage of revenue that translates into profit after all expenses have been deducted. A negative net profit margin, as seen in the data provided for Cytokinetics Inc over multiple quarters, indicates that the company is experiencing losses rather than profits. The fluctuating percentages suggest that the company's expenses are significantly exceeding its revenue, resulting in substantial losses. This sustained negative trend in net profit margin raises concerns about the company's financial performance and its ability to generate profits from its operations. It may indicate issues such as inefficient cost management, declining sales, or other operational challenges that need to be addressed to improve the company's financial health.